openPR Logo
Press release

Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight

05-02-2022 12:46 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Angioedema Market

Angioedema Market

Angioedema is swelling underneath the skin. It's usually a reaction to a trigger, such as a medicine or something you're allergic to. It is not normally serious, but it can be a recurring problem for some people and can very occasionally be life-threatening if it affects breathing.

DelveInsight's "Angioedema Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Angioedema, historical and forecasted epidemiology as well as the Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some facts of Angioedema Market Report are:
• HAE in the US has been observed with the maximum number of diagnosed cases in the age-group 17 to below 65 years, followed by those who belong to the age-group 12 to less than 17 years. DelveInsight's analysts have estimated that there were 882 cases diagnosed for the age group 17 to below 65 years in 2017, among the US population, which is predicted to increase consistently throughout the study period.
• Among the European countries, France had the highest prevalent population of 1,346 cases, followed by the UK which had prevalent population of 1,301 in 2017.
• Type 1 HAE (98.73%) accounted for the majority of Chinese HAE patients, while no type 3 HAE patient has been diagnosed in China to date (Liu et al, 2019).
• According to DelveInsight's analysis, HAE is more prominent in females in comparison to males.

To know more details about Angioedema Market Report, Click here: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Angioedema Market Report
• The report covers the descriptive overview of Angioedema, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Angioedema epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Angioedema is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Angioedema market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Angioedema market

To know more details of Angioedema Market Report, Click here: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Angioedema Drugs are:
• Lanadelumab
• C1 inhibitor concentrate (C1-esteraseremmer-N)
• Icatibant
• Omalizumab
• KVD824
• And Many Others

Some of the Angioedema Companies are:
• Takeda
• Shire Pharmaceuticals
• Prothya Biosolutions
• Novartis
• KalVista Pharmaceuticals
• And Many Others

To know more details about Angioedema Pipeline drugs and Therapies, Click here: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Angioedema
3. Competitive Intelligence Analysis for Angioedema
4. Angioedema: Market Overview at a Glance
5. Angioedema: Disease Background and Overview
6. Patient Journey
7. Angioedema Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Angioedema Unmet Needs
10. Key Endpoints of Angioedema Treatment
11. Angioedema Marketed Products
12. Angioedema Emerging Therapies
13. Angioedema: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Angioedema
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Request for Sample to get detailed TOC: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Reports:

Bacteremia Market
https://www.delveinsight.com/report-store/bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Central Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chondrosarcoma Market
https://www.delveinsight.com/report-store/chondrosarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Microsatellite Stable Colorectal Cancer Market
https://www.delveinsight.com/report-store/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Progressive Multifocal Leukoencephalopathy Market
https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Prosthetic Joint Infection Market
https://www.delveinsight.com/report-store/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Higher-Risk Chronic Myelomonocytic Leukemia Market
https://www.delveinsight.com/report-store/higher-risk-chronic-myelomonocytic-leukemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Upper Limb Hypertonia Market
https://www.delveinsight.com/report-store/upper-limb-hypertonia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

X-linked Retinitis Pigmentosa Market
https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Metachromatic Leukodystrophy Market
https://www.delveinsight.com/report-store/metachromatic-leukodystrophy-mld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Idiopathic Membranous Nephropathy Market
https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Nevoid Basal Cell Carcinoma Syndrome Market
https://www.delveinsight.com/report-store/nevoid-basal-cell-carcinoma-syndrome-nbccs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Refractory Cough Market
https://www.delveinsight.com/report-store/chronic-refractory-cough-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cardiopulmonary Bypass Equipment Market
https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cardiac Biomarkers Testing Devices Market
https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Epithelial Ovarian Cancer Market
https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Surgical Site Infection Ssi Market
https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Keloid Market
https://www.delveinsight.com/report-store/keloid-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Synchronous Endometrial And Ovarian Carcinoma Market
https://www.delveinsight.com/report-store/synchronous-endometrial-and-ovarian-cancer-seoc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Autosomal Recessive Congenital Ichthyosis Market
https://www.delveinsight.com/report-store/autosomal-recessive-congenital-ichthyosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Rituximab Biosimilars Insight
https://www.delveinsight.com/report-store/rituximab-biosimilars-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Adamantinoma Market
https://www.delveinsight.com/report-store/adamantinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Hpv-induced Cancers Market
https://www.delveinsight.com/report-store/hpv-induced-cancers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Continuous Renal Replacement Therapy Machines Market
https://www.delveinsight.com/report-store/continuous-renal-replacement-therapy-machines-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Parkinsons Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

22q11.2 Deletion Syndrome Market
https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Pediatric Growth Hormone Deficiency Pghd Market
https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Brain Aneurysm Stents Market
https://www.delveinsight.com/report-store/brain-aneurysm-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Dermal Erythema Market
https://www.delveinsight.com/report-store/dermal-erythema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Polypoidal Choroidal Vasculopathy Market
https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports as well as customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight here

News-ID: 2615577 • Views:

More Releases from DelveInsight Business Research

Hypertriglyceridemia Pipeline Assessment 2024: Clinical Trials, FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, & Treatment Market by Delveinsight| Merck, Julphar, Eli Lilly, Bristol-Myers Squibb, Pfizer, AbbVie, Sanofi, GlaxoSmithKline
Hypertriglyceridemia Pipeline Assessment 2024: Clinical Trials, FDA, EMA, and PM …
(Albany, United States) As per DelveInsight's assessment, globally, Hypertriglyceridemia pipeline constitutes 20+ key companies continuously working towards developing 20+ Hypertriglyceridemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Hypertriglyceridemia Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hypertriglyceridemia Market. The Hypertriglyceridemia Pipeline report embraces in-depth commercial and clinical assessment of the
Cytomegalovirus (CMV) Infection Pipeline Assessment, 2024: FDA Approvals, Clinical Trials, Treatment Market, Therapies, MOA, ROA by DelveInsight | Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, Moderna, China Immunotec
Cytomegalovirus (CMV) Infection Pipeline Assessment, 2024: FDA Approvals, Clinic …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cytomegalovirus (CMV) Infection pipeline constitutes 15+ key companies continuously working towards developing 20+ Cytomegalovirus (CMV) Infection treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Cytomegalovirus (CMV) Infection Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cytomegalovirus (CMV) Infection Market. The Cytomegalovirus
Vein Illumination Devices Market Trends Analysis, Growth Opportunities and Challenges, Clinical Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast by 2030
Vein Illumination Devices Market Trends Analysis, Growth Opportunities and Chall …
The Vein Illumination Devices market is being driven by a growing geriatric population as well as an increase in the number of surgical operations. The Vein Illumination Devices Market report from DelveInsight provides an in-depth analysis of the Vein Illumination Devices, as well as historical and forecasted market trends in the global market. Vein Illumination Devices Overview Vein illumination devices, also known as vein finders or vein viewers, are medical
Systemic Scleroderma Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, Emerald Health Pharmaceuticals, Kadmon Corporation, Gesynta Pharma, Cumberland Pharma
Systemic Scleroderma Market to Exhibit Rapid Growth Rate During the Forecast Per …
DelveInsight's "Systemic Scleroderma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Systemic Scleroderma, historical and forecasted epidemiology as well as the Systemic Scleroderma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Systemic Scleroderma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Systemic Scleroderma Market Forecast https://www.delveinsight.com/sample-request/systemic-scleroderma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the

All 5 Releases


More Releases for Angioedema

Angioedema Treatment Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Angioedema Treatment market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This report is
Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead. Browse 153 Market Data Tables and 113 Figures spread through
Hereditary Angioedema Market Global Comprehensive Research 2020
Global Hereditary Angioedema Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Hereditary Angioedema Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes
Angioedema Market: Rampant Allergies to Bolster Angioedema Treatment
Angioedema, an edema of spots beneath the skin or mucosa aggravating throat, face, limbs and genitals has taken the lives of more than five thousand people between 1979 and 2010. Unlike urticarial that attacks merely the upper dermis, angioedema strikes the deeper layers, including the dermis, the mucosa, submucosal tissues and the subcutaneous tissue. These assimilations are according to the report titled “Angioedema Market,” which has been recently added to
Angioedema Market: Rampant Allergies to Bolster Angioedema Treatment
Angioedema, an edema of spots beneath the skin or mucosa aggravating throat, face, limbs and genitals has taken the lives of more than five thousand people between 1979 and 2010. Unlike urticarial that attacks merely the upper dermis, angioedema strikes the deeper layers, including the dermis, the mucosa, submucosal tissues and the subcutaneous tissue. These assimilations are according to the report titled “Angioedema Market,” which has been recently added to
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html Superior Healthcare